Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation...
Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation play a role?
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
The aim of this study is to design a population pharmacokinetic study to gain a deeper understanding of the pharmacokinetics of dexamethasone in critically ill COVID-19 patients in order to identify relevant covariates that can be used to personalize dosing regimens.
Blood samples from critically ill patients receiving fixed-dose intravenous dex...
Alternative Titles
Full title
Population pharmacokinetics of dexamethasone in critically ill COVID-19 patients: Does inflammation play a role?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2846927157
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2846927157
Other Identifiers
ISSN
0883-9441
E-ISSN
1557-8615
DOI
10.1016/j.jcrc.2023.154395
